Analysts' Actions: ATU FFIV INTC MET WWD

TheStreet.com

NEW YORK (TheStreet) --

Actuant were downgraded at UBS to neutral. Full valuation, said UBS. Price target goes to $35.

Ampco-Pittsburgh was downgraded to hold at TheStreet Ratings.

Catamaran was upgraded at BMO Capital Markets to outperform from market perform. The shares have been oversold given the Cigna overhang, BMO Capital Markets said. Price target is $59.

F5 Networks was downgraded at Morgan Stanley to equal weight. Maturing ADC market and limited exposure to AWS and mobility access, said Morgan Stanley.

Health Care Reit was downgraded to hold at TheStreet Ratings.

Intel was upgraded at FBR Capital Markets to outperform from market perform. $28 price target. Company can grow in other areas to offset PC losses, FBR Capital Markets said.


ITC Holdings was upgraded at UBS to buy from neutral. Increased confidence in the ETR deal drove the upgrade, UBS said. Price target goes to $95.

Littlefuse was upgraded at Robert Baird to outperform from neutral. $84 price target. Hamlin acquisition should add to earnings, Baird said.

LinkedIn was initiated with an outperform rating at Credit Suisse. $220 price target. Company's addressable market is set to nearly double, Credit Suisse said.


MetLife was upgraded at Deutsche Bank to buy from hold. Limited downside risk and a discounted valuation, said Deutsche Bank. Price target goes to $51.

TripAdvisor was downgraded at Stifel Nicolaus to hold from buy. Valuation call, as the stock moved through the previous $58 price target, Stifel Nicolaus.

Woodward was upgraded at Jefferies to buy. $47 price target. New analyst sees increased visibility for commercial aerospace growth, Jefferies said.

STOCK COMMENTS / EPS CHANGES

Big Lots numbers were reduced at Benchmark. Shares are now seen reaching $35. Estimates were also cut, as the company is seeing lower sales, Benchmark said. Hold rating.

CME Group price target and estimates were raised at UBS. Increased volume upside to the June 10 clearing mandate and solid core business trends, said UBS. Price target goes to $75.

CME Group numbers were increased at Jefferies through 2014. Company is seeing record volumes, Jefferies said. Buy rating and new $78 price target.

Google estimates, price target were raised at Cantor Fitzgerald. Shares are now seen reaching $1,030. Estimates were also increased, given better display growth and EC adoption, Cantor said. Buy rating.

Lululemon price target was raised at Canaccord Genuity. Shares are now seen reaching $92. Company will likely exceed earnings expectations next week, Canaccord said. Buy rating.

Omnicare price target was increased at UBS to $46. Reflects further confidence in the turnaround plan and new repurchase program, said UBS.

Raymond James price target and estimates were raised at Citigroup. Earnings estimates were increased to reflect higher markets and the expectation for lower NIM, said Citigroup. The price target was increased to $46.

Sealed Air was added to the US Focus List at Credit Suisse. New management can pay down debt with solid cash flow, Credit Suisse said. Outperform rating and new $31 price target.


State Street numbers were increased at Jefferies. Estimates were boosted through 2014. Company is leveraged to higher equity markets, Jefferies said. Buy rating and new $75 price target.

Teradyne estimates, price target were raised at Credit Suisse. Shares are now seen reaching $25. Estimates were also increased, as the company is gaining market share, Credit Suisse said. Outperform rating.

Visa price target was boosted at Goldman Sachs to $200. Analyst day should be a positive catalyst for the stock, Goldman said. Buy rating.

>To submit a news tip, email: tips@thestreet.com.

Follow TheStreet on Twitter and become a fan on Facebook.

EXCLUSIVE OFFER: See inside Jim Cramer’s multi-million dollar charitable trust portfolio to see the stocks he thinks could be potentially HUGE winners. Click here to see his holdings for FREE.

Rates

View Comments (0)